Skip to main content
SpringerLink
Log in

CYP2C9: The Support Crew I

  • Chapter
A Case Approach to Perioperative Drug-Drug Interactions

Abstract

This chapter discusses the genetics, metabolic actions, substrates, inducers, and inhibitors of P450 CYP2C9.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Zhou SF, Zhou ZW, Huang M. Polymorphisms of human cytochrome P450 2C9 and the functional relevance. Toxicology. 2010;278(2):165–88.

    Article  PubMed  CAS  Google Scholar 

  2. Miners JO, Birkett DJ. Cytochrome P4502C9: an enzyme of major importance in human drug metabolism. Br J Clin Pharmacol. 1998;45(6):525–38.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  3. Muszkat M. Interethnic differences in drug response: the contribution of genetic variability in ß adrenergic receptor and cytochrome P4502C9. Clin Pharmacol Ther. 2007;82(2):215–8.

    Article  PubMed  CAS  Google Scholar 

  4. Hallberg P, Karlsson J, Kurland L, et al. The CYP2C9 genotype predicts the blood pressure response to irbesartan: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA) trial. J Hypertens. 2002;20(10):2089–93.

    Article  PubMed  CAS  Google Scholar 

  5. Adcock DM, Koftan C, Crisan D, et al. Effect of polymorphisms in the cytochrome P450 CYP2C9 gene on coumadin anticoagulation. Arch Pathol Lab Med. 2004;128(12):1360–3.

    PubMed  CAS  Google Scholar 

  6. Kirchheiner J, Brockmoller J, et al. Clinical consequences of cytochrome P450 2C9 polymorphisms. Clin Pharmacol Ther. 2005;77(1):1–16.

    Article  PubMed  CAS  Google Scholar 

  7. Nation RL, Evans AM, Milne RW. Pharmacokinetic drug interactions with phenytoin (part I). Clin Pharmacokinet. 1990;18:37–60.

    Article  PubMed  CAS  Google Scholar 

  8. Nation RL, Evans AM, Milne RW. Pharmacokinetic drug interactions with phenytoin (part II). Clin Pharmacokinet. 1990;18:131–50.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Anesthesiology, University of California, San Diego, San Diego, CA, USA

    Byron Douglas Fergerson MD

  2. Department of Anesthesiology, University of Utah School of Medicine, Salt Lake City, UT, USA

    Crystal B. Wallentine MD

  3. Department of Anesthesiology, University of Illinois at Chicago, Chicago, IL, USA

    Randal O. Dull MD, PhD

Authors
  1. Byron Douglas Fergerson MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Crystal B. Wallentine MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Randal O. Dull MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Byron Douglas Fergerson MD .

Editor information

Editors and Affiliations

  1. Anesthesia Services Department, Philadelphia Veterans Affairs Med Center, Philadelphia, PA, USA

    Catherine Marcucci MD

  2. Department of Anesthesiology, Oregon Health and Science University, Portland, OR, USA

    Michael P. Hutchens MD

  3. Department of Anesthesiology, Mayo Clinic, Rochester, MN, USA

    Erica D. Wittwer MD, PhD , Toby N. Weingarten MD , Juraj Sprung MD, PhD  & Wayne T. Nicholson MD, PharmD, MSc , ,  & 

  4. Department of Anesthesiology and Perioperative Medicine, Oregon Health and Science University, Portland, OR, USA

    Kirk Lalwani MD

  5. Department of Anesthesiology, University of Pittsburgh School of Med Liliane S. Kaufmann Building, Pittsburgh, PA, USA

    David G. Metro MD

  6. Department of Anesthesiology, University of Illinois at Chicago, Chicago, IL, USA

    Randal O. Dull MD, PhD

  7. Department of Anesthesiology, Perioperative Medicine, Oregon Health and Science University, Portland, OR, USA

    Christopher E. Swide MD

  8. Department of Learning Health Sciences, University of Michigan Medical School, Ann Arbor, MI, USA

    F. Jacob Seagull PhD

  9. Department of Anesthesiology and Perioperative Medicine, Portland, OR, USA

    Jeffrey R. Kirsch MD (Professor and Chair) (Professor and Chair)

  10. Department of Psychiatry, University of Maryland Medical System VA Maryland Health Care System, Baltimore, MD, USA

    Neil B. Sandson MD

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Fergerson, B.D., Wallentine, C.B., Dull, R.O. (2015). CYP2C9: The Support Crew I. In: Marcucci, C., et al. A Case Approach to Perioperative Drug-Drug Interactions. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-7495-1_10

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-7495-1_10

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-7494-4

  • Online ISBN: 978-1-4614-7495-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation